Historical Valuation
Imunon Inc (IMNN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.41. The fair price of Imunon Inc (IMNN) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：3.86
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Imunon Inc (IMNN) has a current Price-to-Book (P/B) ratio of 2.80. Compared to its 3-year average P/B ratio of 3.81 , the current P/B ratio is approximately -26.51% higher. Relative to its 5-year average P/B ratio of 2.75, the current P/B ratio is about 2.02% higher. Imunon Inc (IMNN) has a Forward Free Cash Flow (FCF) yield of approximately -123.29%. Compared to its 3-year average FCF yield of -170.36%, the current FCF yield is approximately -27.63% lower. Relative to its 5-year average FCF yield of -132.58% , the current FCF yield is about -7.01% lower.
P/B
Median3y
3.81
Median5y
2.75
FCF Yield
Median3y
-170.36
Median5y
-132.58
Competitors Valuation Multiple
AI Analysis for IMNN
The average P/S ratio for IMNN competitors is 4.56, providing a benchmark for relative valuation. Imunon Inc Corp (IMNN.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for IMNN
1Y
3Y
5Y
Market capitalization of IMNN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of IMNN in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is IMNN currently overvalued or undervalued?
Imunon Inc (IMNN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.41. The fair price of Imunon Inc (IMNN) is between NaN to NaN according to relative valuation methord.
What is Imunon Inc (IMNN) fair value?
IMNN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Imunon Inc (IMNN) is between NaN to NaN according to relative valuation methord.
How does IMNN's valuation metrics compare to the industry average?
The average P/S ratio for IMNN's competitors is 4.56, providing a benchmark for relative valuation. Imunon Inc Corp (IMNN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Imunon Inc (IMNN) as of Jan 09 2026?
As of Jan 09 2026, Imunon Inc (IMNN) has a P/B ratio of 2.80. This indicates that the market values IMNN at 2.80 times its book value.
What is the current FCF Yield for Imunon Inc (IMNN) as of Jan 09 2026?
As of Jan 09 2026, Imunon Inc (IMNN) has a FCF Yield of -123.29%. This means that for every dollar of Imunon Inc’s market capitalization, the company generates -123.29 cents in free cash flow.
What is the current Forward P/E ratio for Imunon Inc (IMNN) as of Jan 09 2026?
As of Jan 09 2026, Imunon Inc (IMNN) has a Forward P/E ratio of -0.77. This means the market is willing to pay $-0.77 for every dollar of Imunon Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Imunon Inc (IMNN) as of Jan 09 2026?
As of Jan 09 2026, Imunon Inc (IMNN) has a Forward P/S ratio of 0.00. This means the market is valuing IMNN at $0.00 for every dollar of expected revenue over the next 12 months.